Phase <scp>I</scp>/<scp>II</scp> trial assessing bendamustine plus bortezomib combination therapy for the treatment of patients with relapsed or refractory multiple myelomaJames R. Berenson, Debra Mayo, Stephen J. Noga et al.|British Journal of Haematology|2012Cited by 53
Bendamustine Combined with Bortezomib Has Efficacy in Patients with Relapsed or Refractory Multiple Myeloma: A Phase 1/2 StudyJames R. Berenson, Debra Mayo, Ori Yellin et al.|Blood|2011Cited by 6